Lifeboat Foundation

A recent study, affiliated with South Korea’s Ulsan National Institute of Science and Technology (UNIST) has introduced a novel targeted drug delivery system in the fight against cancer.

The future of medicine involves the precise engineering of human cells. Turns out, that future may not include that promising CRISPR technique.

Can cutting-edge new treatments and therapies put an end to cardiovascular and circulatory disease for good?

WASHINGTON — A new study offers some of the strongest evidence yet of the connection between the marketing of opioids to doctors and the nation’s addiction epidemic.

It found that counties where opioid manufacturers offered a large number of gifts and payments to doctors had more overdose deaths involving the drugs than counties where direct-to-physician marketing was less aggressive.

The study, published Friday in JAMA Network Open, said the industry spent about $40 million promoting opioid medications to nearly 68,000 doctors from 2013 through 2015, including by paying for meals, trips and consulting fees. And it found that for every three additional payments that companies made to doctors per 100,000 people in a county, overdose deaths involving prescription opioids there a year later were 18 percent higher.

Continue reading “Study Links Drug Maker Gifts for Doctors to More Overdose Deaths” »

A broader range of treatments for this disorder offers patients a more personalized approach.

• By David Blum on January 18, 2019

Clinical trial compares stem cell transplantation with existing disease-modifying therapies and finds that the former is more effective at slowing down MS.

A vocal minority in the United States is intent on stopping federal funding for research using human fetal tissue, citing stem cell–based or other alternatives as adequate. This view is scientifically inaccurate. It ignores the current limitations of stem cell research and disregards the value of fetal tissue research in finding therapies for incurable diseases. If there is to be continued rapid progress in treating cancer, birth defects, heart disease, and infectious diseases, then we need fetal tissue research.

Ultrasound technology has been in wide use for decades, helping submarines navigate and letting doctors non-invasively peer inside patients, but it might be about to get a whole lot more powerful. Researchers have developed an “ultra” ultrasound sensor that is so sensitive it can hear air molecules moving around or the vibrations of individual cells.

Age-related macular degeneration is the leading cause of vision loss in seniors, and existing treatments are few.

But now, experiments in pigs and rats suggest that stem cell therapy might help curb at least one form of the disease.

The results could soon lead to the first human trials of this therapy for macular degeneration, according to researchers from the U.S. National Eye Institute (NEI).

Continue reading “Stem cell therapy shows early promise against macular degeneration” »